Your browser doesn't support javascript.
loading
A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance).
Vij, Ravi; Le-Rademacher, Jennifer; Laumann, Kristina; Hars, Vera; Owzar, Kouros; Shore, Tsiporah; Vasu, Sumithira; Cashen, Amanda; Isola, Luis; Shea, Thomas; DeMagalhaes-Silverman, Margarida; Hurd, David; Meehan, Kenneth; Beardell, Frank; Devine, Steven.
Afiliação
  • Vij R; Division of Medical Oncology, Washington University School of Medicine, St. Louis, Missouri. Electronic address: rvij@wustl.edu.
  • Le-Rademacher J; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota.
  • Laumann K; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota.
  • Hars V; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Owzar K; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Shore T; Division of Hematology/Medical Oncology, Weill Medical College of Cornell University, New York, New York.
  • Vasu S; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Cashen A; Division of Medical Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Isola L; Hematology and Oncology, Mt. Sinai Hospital, New York, New York.
  • Shea T; Bone Marrow Transplant and Cellular Therapy Program, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • DeMagalhaes-Silverman M; Blood and Marrow Transplant Program, University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa.
  • Hurd D; Hematology and Oncology, Wake Forest University Health Sciences, Winston-Salem, North Carolina.
  • Meehan K; Blood and Marrow Transplant Program, Dartmouth-Hitchcock Medical Center/Norris Cotton Cancer Center, Lebanon, New Hampshire.
  • Beardell F; Hematology and Oncology, Christiana Care Health System, Newark, Delaware.
  • Devine S; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Biol Blood Marrow Transplant ; 25(10): 1984-1992, 2019 10.
Article em En | MEDLINE | ID: mdl-31212080
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Transplante Homólogo / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Transplante Homólogo / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article